1-4 of 4
Daniel G. Haller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

New Approaches to Assessing and Treating Early-Stage Colon and Rectal Cancer: Summary Statement from 2007 Santa Monica Conference

Lee S. Rosen, Anton J. Bilchik, Robert W. Beart, Jr., Al B. Benson, III, Kenneth J. Chang, Carolyn C. Compton, Axel Grothey, Daniel G. Haller, Clifford Y. Ko, Patrick M. Lynch, Heidi Nelson, Michael J. Stamos, Roderick R. Turner, Christopher G. Willett
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (22): 6853s–6856s.
https://doi.org/10.1158/1078-0432.CCR-07-1629
Published: 15 November 2007
View article titled, New Approaches to Assessing and Treating Early-Stage Colon and Rectal Cancer: Summary Statement from 2007 Santa Monica Conference
Open the PDF for New Approaches to Assessing and Treating Early-Stage Colon and Rectal Cancer: Summary Statement from 2007 Santa Monica Conference in another window
Journal Articles

A Phase I Trial of the Dual Farnesyltransferase and Geranylgeranyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Pancreatic Cancer

Neil E. Martin, Thomas B. Brunner, Krystina D. Kiel, Thomas F. DeLaney, William F. Regine, Mohammed Mohiuddin, Ernest F. Rosato, Daniel G. Haller, James P. Stevenson, Debbie Smith, Barnali Pramanik, Joel Tepper, Wesley K. Tanaka, Briggs Morrison, Paul Deutsch, Anjali K. Gupta, Ruth J. Muschel, W. Gillies McKenna, Eric J. Bernhard, Stephen M. Hahn
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (16): 5447–5454.
https://doi.org/10.1158/1078-0432.CCR-04-0248
Published: 24 August 2004
View article titled, A Phase I Trial of the Dual Farnesyltransferase and Geranylgeranyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Pancreatic Cancer
Open the PDF for A Phase I Trial of the Dual Farnesyltransferase and Geranylgeranyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Pancreatic Cancer in another window
Journal Articles

Phase I and Pharmacokinetic Trial of the Novel Taxane BMS-184476 Administered as a 1-Hour Intravenous Infusion in Combination with Cisplatin Every 21 Days

Weijing Sun, James P. Stevenson, Maryann L. Gallagher, David Vaughn, Steven M. Hahn, Daniel G. Haller, Marvin Cohen, Justin Kopit, Gilles Gallant, Peter J. O’Dwyer
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5221–5227.
Published: 12 November 2003
View article titled, Phase I and Pharmacokinetic Trial of the Novel Taxane BMS-184476 Administered as a 1-Hour Intravenous Infusion in Combination with Cisplatin Every 21 Days
Open the PDF for Phase I and Pharmacokinetic Trial of the Novel Taxane BMS-184476 Administered as a 1-Hour Intravenous Infusion in Combination with Cisplatin Every 21 Days in another window
Journal Articles

A Phase I Trial of the Farnesyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Lung and Head and Neck Cancer

Stephen M. Hahn, Eric J. Bernhard, William Regine, Mohammed Mohiuddin, Daniel G. Haller, James P. Stevenson, Debbie Smith, Barnali Pramanik, Joel Tepper, Thomas F. DeLaney, Krystina D. Kiel, Briggs Morrison, Paul Deutsch, Ruth J. Muschel, W. Gillies McKenna
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (5): 1065–1072.
Published: 01 May 2002
View article titled, A Phase I Trial of the Farnesyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Lung and Head and Neck Cancer
Open the PDF for A Phase I Trial of the Farnesyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Lung and Head and Neck Cancer in another window